Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS ...

This November, the nonprofit I AM ALS is launching a peer support program as part of its new campaign focused on supporting ...

The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...

Columnist Kristin Neva and her husband with ALS are sometimes asked about the way they went about building their accessible home.

Mitochondrial genome mutations may be linked to ALS, per a study, opening the door for new ways to diagnosing and treating ...